Along these lines, human umbilical cord mesenchymal stem cell-derived EVs, orally administered to both healthy mice and animals suffering from CCl4-induced liver failure, accumulated in the liver, which correlated with a dose-dependent inhibition of liver destruction, an antioxidant effect in hepatocytes and a reduction in serum ALT and AST levels. Here, GPT is linked to Hepatic failure.